BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 14666564)

  • 1. Going back in time. Citing cost efficiency, plans offer narrow networks.
    Benko LB
    Mod Healthc; 2003 Nov; 33(47):14-5. PubMed ID: 14666564
    [No Abstract]   [Full Text] [Related]  

  • 2. The dynamics of power in the marketplace.
    Cochrane JD
    Integr Healthc Rep; 1998 Jul; ():1-5. PubMed ID: 10182826
    [No Abstract]   [Full Text] [Related]  

  • 3. Your newest competitors: alternative-medicine networks.
    Grandinetti DA
    Med Econ; 1999 May; 76(10):44, 46, 51. PubMed ID: 10537717
    [No Abstract]   [Full Text] [Related]  

  • 4. HMOs dump more Medicare patients.
    Bloice C
    Revolution (Oakl); 2003; 4(5):9. PubMed ID: 14631718
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of Blues' costs offers fascinating insights.
    Capitation Rates Data; 2000 May; 5(5):49-51. PubMed ID: 11066969
    [No Abstract]   [Full Text] [Related]  

  • 6. The Blues rise again. Amid industry turmoil, trademark seen as refuge.
    Benko LB
    Mod Healthc; 2002 Sep; 32(36):14-5. PubMed ID: 12298320
    [No Abstract]   [Full Text] [Related]  

  • 7. Gatekeeper products losing favor in many markets.
    Manag Care Strateg; 1998 Nov; 6(11):126, 131-3. PubMed ID: 10351372
    [No Abstract]   [Full Text] [Related]  

  • 8. Blues plan more HMO involvement.
    Employee Benefit Plan Rev; 1978 Sep; 33(3):34. PubMed ID: 10277895
    [No Abstract]   [Full Text] [Related]  

  • 9. Consumer-choice markets: lessons from FEHBP mental health coverage.
    Foote SM; Jones SB
    Health Aff (Millwood); 1999; 18(5):125-30. PubMed ID: 10495599
    [No Abstract]   [Full Text] [Related]  

  • 10. Maxicare fallout: will CA Blue Cross be next?
    Larkin H
    Hospitals; 1989 May; 63(9):49. PubMed ID: 2707776
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulling up stakes. Anthem's Ohio exit may signal Medicare risk HMO trend.
    Rauber C
    Mod Healthc; 1998 Jun; 28(24):26. PubMed ID: 10181113
    [No Abstract]   [Full Text] [Related]  

  • 12. The future of the gatekeeper. Some organizations are finding ways to modify the "gatekeeper" role and meet the public's demand for increased access.
    Nilson JT
    Healthc Exec; 1998; 13(4):18-22. PubMed ID: 10181096
    [No Abstract]   [Full Text] [Related]  

  • 13. Avoiding the pitfalls of capitation and other HMO-physician provider agreements.
    Finney LD
    Benders Health Care Law Mon; 1996 Jan; ():3-10. PubMed ID: 10158208
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors affecting patients' self-referral to specialists.
    Hsu J; Go AS; Selby J
    JAMA; 2001 Aug; 286(6):672-3. PubMed ID: 11495614
    [No Abstract]   [Full Text] [Related]  

  • 15. Health maintenance organizations and the role of antitrust law.
    Kissam PC
    Duke Law J; 1978 May; (2):487-541. PubMed ID: 10239065
    [No Abstract]   [Full Text] [Related]  

  • 16. Health plan responses to managed care regulation.
    Hurley RE; Draper DA
    Manag Care Q; 2002; 10(4):30-42. PubMed ID: 12561392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency care under managed care: a fatal distraction?
    Henry GL
    Health Syst Rev; 1996; 29(2):55-6, 58, 60-2. PubMed ID: 10156521
    [No Abstract]   [Full Text] [Related]  

  • 18. Not-for-profit HMOs.
    Burrell CE
    Bull N Y Acad Med; 1987; 63(1):61-7. PubMed ID: 3470098
    [No Abstract]   [Full Text] [Related]  

  • 19. What you can bargain for when HMOs compete.
    Azevedo D
    Bus Health; 1995 Jun; 13(6):44-5, 48, 50 passim. PubMed ID: 10164757
    [No Abstract]   [Full Text] [Related]  

  • 20. Blue shield of California's Access+ HMO.
    Richard K; Wood K
    Health Aff (Millwood); 1999; 18(3):174-7. PubMed ID: 10388214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.